Antiepileptic potential and behavioral profile of l-pGlu-(2-propyl)–l-His–l-ProNH2, a newer thyrotropin-releasing hormone analog

Colson, 2006, Thyrotropin-releasing hormone analogs, Mini Rev Med Chem, 6, 221, 10.2174/138955706775476019 Gary, 2003, The thyrotropin-releasing hormone (TRH) hypothesis of homeostatic regulation: implications for TRH-based therapeutics, J Pharmacol Exp Ther, 305, 410, 10.1124/jpet.102.044040 Czapinski, 2005, Mechanisms of action of antiepileptic drugs, Curr Top Med Chem, 5, 3, 10.2174/1568026053386962 Johannessen Landmark, 2008, Pharmacological management of epilepsy: recent advances and future prospects, Drugs, 68, 1925, 10.2165/00003495-200868140-00001 De Gortari, 2006, Amygdala kindling differentially regulates the expression of the elements involved in TRH transmission, Neurochem Int, 48, 31, 10.1016/j.neuint.2005.08.003 Kreider, 1990, Systemic administration of kainic acid produces elevations in TRH in rat central nervous system, Regul Pept, 28, 83, 10.1016/0167-0115(90)90066-6 Jaworska-Feil, 2001, Protective effects of TRH and its stable analogue, RGH-2202, on kainate-induced seizures and neurotoxicity in rodents, Epilepsy Res, 43, 67, 10.1016/S0920-1211(00)00178-9 Kubek, 2002, Thyrotropin-releasing hormone in the treatment of intractable epilepsy, Pediatr Neurol, 26, 9, 10.1016/S0887-8994(01)00321-6 Momiyama, 1996, Long-term antiepileptic effects of chronic intake of CNK-602A, a thyrotropin-releasing hormone analogue, on spontaneously epileptic rats, Epilepsia, 37, 328, 10.1111/j.1528-1157.1996.tb00567.x Ogawa, 1985, Involvement of thyrotropin-releasing hormone (TRH) neural system of the brain in pentylenetetrazol-induced seizures, Regul Pept, 12, 249, 10.1016/0167-0115(85)90066-7 Inanaga, 1989, Clinical study of oral administration of DN-1417, a TRH analog, in patients with intractable epilepsy, Epilepsia, 30, 438, 10.1111/j.1528-1157.1989.tb05323.x Cao, 1998, Cloning and characterization of a cDNA encoding a novel subtype of rat thyrotropin-releasing hormone receptor, J Biol Chem, 273, 32281, 10.1074/jbc.273.48.32281 Heuer, 2000, Expression of thyrotropin-releasing hormone receptor 2 (TRH-R2) in the central nervous system of rats, J Comp Neurol, 428, 319, 10.1002/1096-9861(20001211)428:2<319::AID-CNE10>3.0.CO;2-9 Sun, 2003, Thyrotropin-releasing hormone receptors: similarities and differences, J Mol Endocrinol, 30, 87, 10.1677/jme.0.0300087 Griffiths, 1989, Comparative metabolism and conformation of TRH and its analogues, Ann NY Acad Sci, 553, 217, 10.1111/j.1749-6632.1989.tb46645.x Engel, 2006, Low affinity analogs of thyrotropin-releasing hormone are super-agonists, J Biol Chem, 281, 13103, 10.1074/jbc.M600440200 Jain, 2002, Synthesis and biology of new thyrotropin-releasing hormone (TRH) analogues, Bioorg Med Chem, 10, 189, 10.1016/S0968-0896(01)00265-6 Kaur, 2005, Thyrotropin-releasing hormone (TRH) analogues that exhibit selectivity to TRH receptor subtype 2, J Med Chem, 48, 6162, 10.1021/jm0505462 Kaur, 2007, Modifications of the pyroglutamic acid and histidine residues in thyrotropin-releasing hormone (TRH) yield analogs with selectivity for TRH receptor type 2 over type 1, Bioorg Med Chem, 15, 433, 10.1016/j.bmc.2006.09.045 Lloyd, 2001, Antidepressant effects of thyrotropin-releasing hormone analogues using a rodent model of depression, Pharmacol Biochem Behav, 70, 15, 10.1016/S0091-3057(01)00555-X Pekary, 2004, Valproate modulates TRH receptor, TRH and TRH-like peptide levels in rat brain, Peptides, 25, 647, 10.1016/j.peptides.2004.01.016 Scalabrino, 2007, Discovery of a dual action first-in-class peptide that mimics and enhances CNS-mediated actions of thyrotropin-releasing hormone, Neuropharmacology, 52, 1472, 10.1016/j.neuropharm.2007.02.003 Jain R, Monga V, Kaur N, et al. CNS effective thyrotropin releasing hormone analogs. WTO Indian Patent Application No. 2065/DEL/2006. Wu, 2002, Synthesis and biological evaluations of brain-targeted chemical delivery systems of [Nva2]-TRH, J Pharm Pharmacol, 54, 945, 10.1211/002235702760089063 Malhotra, 1997, Effect of adenosine receptor modulation on pentylenetetrazole-induced seizures in rats, Br J Pharmacol, 120, 282, 10.1038/sj.bjp.0700869 Manocha, 2003, Studies on the anticonvulsant effect of U50488H on maximal electroshock seizure in mice, Pharmacol Biochem Behav, 76, 111, 10.1016/S0091-3057(03)00218-1 Mendyk, 2001, Influence of new gamma-aminobutyric acid amide derivatives and its phthalimide precursors on the central nervous system activity in mice, Pol J Pharmacol, 53, 689 Amabeoku, 1999, Gamma-aminobutyric acid and glutamic acid receptors may mediate theophylline-induced seizures in mice, Gen Pharmacol, 32, 365, 10.1016/S0306-3623(98)00201-8 Sharma, 2007, FeTPPS protects against global cerebral ischemic–reperfusion injury in gerbils, Pharmacol Res, 55, 335, 10.1016/j.phrs.2007.01.002 Hubler, 2005, Functional observational battery and motor activity in rats after single administration of two NHE 1 inhibitors, Toxicol Appl Pharmacol, 208, 266, 10.1016/j.taap.2005.02.017 Billes, 2008, Catecholamine reuptake inhibition causes weight loss by increasing locomotor activity and thermogenesis, Neuropsychopharmacology, 33, 1287, 10.1038/sj.npp.1301526 Nillni, 1999, The biology of pro-thyrotropin-releasing hormone-derived peptides, Endocr Rev, 20, 599 Horita, 1989, TRH analog MK-771 reverses neurochemical and learning deficits in medial septal-lesioned rats, Peptides, 10, 121, 10.1016/0196-9781(89)90087-9 Deng, 2006, Thyrotropin-releasing hormone increases GABA release in rat hippocampus, J Physiol, 577, 497, 10.1113/jphysiol.2006.118141 Koskinen, 2000, Cerebrovascular effects of the TRH analogues pGlu-3-methyl-His-Pro amide and pGlu-Glu-Pro amide: a comparison with TRH, Ups J Med Sci, 105, 73, 10.1517/03009734000000049 Shinozuka, 1997, Effects of thyrotropin-releasing hormone and its analogue, NS-3, on blood pressure, heart rate, and serum catecholamine levels in rats, Gen Pharmacol, 28, 209, 10.1016/S0306-3623(96)00219-4